News
Uncategorized

Wednesday, February 24, 2016

Stemedica International Receives Approval from Emory University to Initiate Alzheimer’s Disease Study with Adult Allogeneic Stem Cells

Lausanne, Switzerland — February 24, 2016 — Stemedica International, SA, a leader in the development of innovative stem cell-based treatments for Alzheimer’s Disease announced today that it has received IRB approval from Emory University in Atlanta, Georgia to initiate a clinical study entitled, “A Phase IIa Multicenter, Randomized, Single-blind, Placebo-controlled, Crossover Study to Assess the… click Read Entire Article
viagra generico on line http://www.hemsleyandhemsley.com/equivalent-viagra-pharmacie/ http://projects.csail.mit.edu/gsl/signup/?may=term-paper-layout